Endocrine Abstracts

Introduction and objective: Treatment with integrated continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring systems (CGM) helps to improve glycaemic control in people with type 1 diabetes mellitus (DM1). There is increasing use in pregnant women, but there are no protocols for its continuation during delivery. The aim of this work is to analyse glycaemic control during pregnancy, in addition to studying obstetric and neonatal outcomes.<p class="...